Disease & disorder
dermatomyositis
MONDO:0016367
Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
9 shownExploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesNCT07558850 · 2026-05-10
RECRUITINGA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101NCT07403188 · 2025-11-24
RECRUITINGHome Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic DiseasesNCT06732674 · 2024-12-16
RECRUITINGRheumatology Patient Registry and BiorepositoryNCT04402086 · 2020-08-04
RECRUITINGTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16
RECRUITINGSafety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseNCT06056921 · 2023-08-31
UNKNOWNDenosumab for Glucocorticoid-treated Children With Rheumatic DisordersNCT02418273 · 2019-08-01
WITHDRAWNA Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisNCT03817424 · 2018-12-13
COMPLETEDPilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersNCT00010335 · 2000-11-01
COMPLETEDDrugs being studied
Research locations
BirminghamAlabama, United States2New HavenConnecticut, United States2PhiladelphiaPennsylvania, United States2AtlantaGeorgia, United States1BaltimoreMaryland, United States1BarcelonaSpain1BethesdaMaryland, United States1BialystokPoland1BostonMassachusetts, United States1BydgoszczPoland1CharlotteNorth Carolina, United States1ChicagoIllinois, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.